Toremifene
Back to searchMolecule Structure
Scientific Name
Toremifene
Description of the Drug
Toremifene is a first generation nonsteroidal selective estrogen receptor modulator used to treat certain breast cancers.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00539
http://www.drugbank.ca/drugs/DB00539
Brand Name(s)
Not Available
Company Owner(s)
Kyowa Kirin Inc, Msn Laboratories Private Ltd, Rising Pharma Holdings Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Estrogen receptor | PROTEIN FAMILY | MODULATOR | CHEMBL2093866 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL7465 | ||
PharmGKB | PA451731 | ||
Human Metabolome Database | HMDB0014679 | ||
DrugBank | DB00539 | ||
PubChem: Thomson Pharma | 14757386 | ||
PubChem | 3005573 | ||
LINCS | LSM-42973 | ||
Nikkaji | J33.157K | J745.747B | |
PDBe | T0R | ||
BindingDB | 58492 | ||
EPA CompTox Dashboard | DTXSID3023689 | ||
DrugCentral | 2709 | ||
Brenda | 256274 | ||
ChemicalBook | CB0287854 | ||
Guide to Pharmacology | 4325 | ||
rxnorm | TOREMIFENE | TOREMIFENE CITRATE | FARESTON |
PubChem: Drugs of the Future | 12013627 | ||
KEGG Ligand | C08166 | ||
ChEBI | 9635 | ||
ZINC | ZINC000012404516 |